These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 7053253

  • 1. Phase II study of divided-dose vinblastine in non-small cell bronchogenic carcinoma.
    Schulman P, Budman DR, Vinciguerra V, Weiselberg L, Abrams S, Degnan T.
    Cancer Treat Rep; 1982 Jan; 66(1):171-2. PubMed ID: 7053253
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma.
    Schulman P, Budman DR, Weiselberg L, Vinciguerra V, Degnan TJ.
    Cancer Treat Rep; 1983 Oct; 67(10):943-5. PubMed ID: 6684988
    [Abstract] [Full Text] [Related]

  • 3. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ, Peterson BA, Kennedy BJ, Vosika GJ, Conroy JA.
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [Abstract] [Full Text] [Related]

  • 4. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW, Palmer JB, Pratt MA, Clark RA.
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract] [Full Text] [Related]

  • 5. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Nov; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 6. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.
    Osterlind K, Dombernowsky P, Sørensen PG, Hansen HH.
    Cancer Treat Rep; 1981 Nov; 65(3-4):245-8. PubMed ID: 6263469
    [Abstract] [Full Text] [Related]

  • 7. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV.
    Cancer; 1996 Oct 15; 78(8):1701-7. PubMed ID: 8859183
    [Abstract] [Full Text] [Related]

  • 8. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug 15; 10(8):1838-43. PubMed ID: 6882007
    [Abstract] [Full Text] [Related]

  • 9. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Apr 15; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [Abstract] [Full Text] [Related]

  • 10. Phase II trial of vindesine in patients with small cell lung carcinoma.
    Natale RB, Gralla RJ, Wittes RE.
    Cancer Treat Rep; 1981 Apr 15; 65(1-2):129-31. PubMed ID: 6261946
    [No Abstract] [Full Text] [Related]

  • 11. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE.
    Cancer J Sci Am; 1995 Apr 15; 1(4):288-94. PubMed ID: 9166490
    [Abstract] [Full Text] [Related]

  • 12. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network.
    Langer CJ, Millenson M, Rosvold E, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1997 Aug 15; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128
    [Abstract] [Full Text] [Related]

  • 13. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
    Langer CJ, Millenson M, O'Dwyer P, Kosierowski R, Alexander R, Litwin S, McAleer CA, Bonjo CA, Ozols R.
    Semin Oncol; 1996 Dec 15; 23(6 Suppl 16):35-41. PubMed ID: 9007119
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [Abstract] [Full Text] [Related]

  • 15. Vindesine: an effective agent in the treatment of non-small cell lung cancer.
    Furnas BE, Williams SD, Einhorn LH, Cobleigh MA.
    Cancer Treat Rep; 1982 Sep 15; 66(9):1709-11. PubMed ID: 7116347
    [Abstract] [Full Text] [Related]

  • 16. Phase II trial of bisantrene for unresectable non-small cell bronchogenic carcinoma: an Illinois Cancer Council study.
    McGuire WP, Blough RR, Cobleigh MA, Johnson CM, Kukla LJ, Lad TE, Lanzotti VJ, Stiff PJ, Zawila P.
    Cancer Treat Rep; 1983 Sep 15; 67(9):841-2. PubMed ID: 6883363
    [No Abstract] [Full Text] [Related]

  • 17. Phase II study of a biweekly regimen of vinorelbine and cisplatin in advanced non-small cell lung cancer.
    Chen CH, Lin CM, Kao KC, Chang JW, Tsao TC.
    Chang Gung Med J; 2007 Sep 15; 30(3):249-55. PubMed ID: 17760276
    [Abstract] [Full Text] [Related]

  • 18. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P, Ciuleanu TE, Cernea D, Pelau D, Gaal V, Cebotaru C, Guttman T, Todor N, Ghilezan N.
    J BUON; 2007 Sep 15; 12(1):33-9. PubMed ID: 17436399
    [Abstract] [Full Text] [Related]

  • 19. Vindesine in the treatment of squamous cell carcinoma, adenocarcinoma, and large cell carcinoma of the lung.
    Osterlind K, Hørbov S, Dombernowsky P, Rørth M, Hansen HH.
    Cancer Treat Rep; 1982 Feb 15; 66(2):305-9. PubMed ID: 7055816
    [Abstract] [Full Text] [Related]

  • 20. Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate.
    Krug LM, Ng KK, Kris MG, Miller VA, Tong W, Heelan RT, Leon L, Leung D, Kelly J, Grant SC, Sirotnak FM.
    Clin Cancer Res; 2000 Sep 15; 6(9):3493-8. PubMed ID: 10999734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.